110 related articles for article (PubMed ID: 21851386)
1. Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats.
Sae-Ung K; Uéda K; Govitrapong P; Phansuwan-Pujito P
J Pineal Res; 2012 Jan; 52(1):128-37. PubMed ID: 21851386
[TBL] [Abstract][Full Text] [Related]
2. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
3. Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
Klongpanichapak S; Phansuwan-Pujito P; Ebadi M; Govitrapong P
Neurosci Lett; 2008 May; 436(3):309-13. PubMed ID: 18406059
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of melatonin on amphetamine-induced dopaminergic fiber degeneration in the hippocampus of postnatal rats.
Leeboonngam T; Pramong R; Sae-Ung K; Govitrapong P; Phansuwan-Pujito P
J Pineal Res; 2018 Apr; 64(3):. PubMed ID: 29149481
[TBL] [Abstract][Full Text] [Related]
5. Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum.
Mukda S; Vimolratana O; Govitrapong P
Neurosci Lett; 2011 Jan; 488(2):154-7. PubMed ID: 21078367
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
8. Effect of melatonin on D-amphetamine-induced neuroglial alterations in postnatal rat hippocampus and prefrontal cortex.
Permpoonputtana K; Mukda S; Govitrapong P
Neurosci Lett; 2012 Aug; 524(1):1-4. PubMed ID: 22796652
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
[TBL] [Abstract][Full Text] [Related]
10. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Mao L; Wang JQ
Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
[TBL] [Abstract][Full Text] [Related]
11. Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein.
Lin AM; Fang SF; Chao PL; Yang CH
J Pineal Res; 2007 Sep; 43(2):163-71. PubMed ID: 17645694
[TBL] [Abstract][Full Text] [Related]
12. Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity.
Klongpanichapak S; Phansuwan-Pujito P; Ebadi M; Govitrapong P
J Pineal Res; 2007 Aug; 43(1):65-73. PubMed ID: 17614837
[TBL] [Abstract][Full Text] [Related]
13. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced changes in dopamine receptors in early postnatal rat brain.
Mukda S; Kaewsuk S; Ebadi M; Govitrapong P
Dev Neurosci; 2009; 31(3):193-201. PubMed ID: 19145071
[TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent anion channel involved in the α-synuclein-induced dopaminergic neuron toxicity in rats.
Lu L; Zhang C; Cai Q; Lu Q; Duan C; Zhu Y; Yang H
Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):170-8. PubMed ID: 23291291
[TBL] [Abstract][Full Text] [Related]
16. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
Park SS; Schulz EM; Lee D
Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
[TBL] [Abstract][Full Text] [Related]
17. Effects of amphetamine on serotoninergic and GABAergic expression of developing brain.
Yin HS; Tan HW
Neurotoxicol Teratol; 2007; 29(2):264-72. PubMed ID: 17137750
[TBL] [Abstract][Full Text] [Related]
18. Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody.
Zhang L; Zhang C; Zhu Y; Cai Q; Chan P; Uéda K; Yu S; Yang H
Brain Res; 2008 Dec; 1244():40-52. PubMed ID: 18817762
[TBL] [Abstract][Full Text] [Related]
19. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
Shavali S; Carlson EC; Swinscoe JC; Ebadi M
J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates.
Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA
Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
